ARCH Venture Fund

ARCH Venture Partners is a premier venture capital firm that specializes in the creation and funding of seed and early-stage technology companies, with a primary focus on the life sciences and healthcare sectors. Founded in 1986, the firm is renowned for its 'company creation' model, often partnering with leading academic researchers and institutions to translate breakthrough scientific discoveries into clinical-stage biotechnology companies. ARCH has been instrumental in the founding of numerous high-profile biotech firms, including Illumina, Alnylam Pharmaceuticals, Juno Therapeutics, and Sana Biotechnology. The firm manages billions of dollars across multiple funds and maintains a global presence with offices in major biotech hubs.